CARM1 and breast cancer: To enable high-throughput screening for CARM1 degraders, we generateda HiBiT-CARM1 cell line using CRISPR/cas9-mediated knock-in technology.The HiBiT tag was inserted at the N-terminus of endogenous CARM1 inestrogen receptor-positive breast cancer cell line MCF7 (Figure A).